127 related articles for article (PubMed ID: 21273790)
1. Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation.
Henschkowski J; Bischoff-Ferrari HA; Wüthrich RP; Serra AL
Kidney Blood Press Res; 2011; 34(2):97-103. PubMed ID: 21273790
[TBL] [Abstract][Full Text] [Related]
2. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2007 Aug; 22(8):2362-5. PubMed ID: 17510094
[TBL] [Abstract][Full Text] [Related]
3. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism.
Schwarz A; Merkel S; Leitolf H; Haller H
Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318
[TBL] [Abstract][Full Text] [Related]
4. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
[TBL] [Abstract][Full Text] [Related]
5. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
[TBL] [Abstract][Full Text] [Related]
6. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.
Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP
Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients.
Borstnar S; Erzen B; Gmeiner Stopar T; Kocjan T; Arnol M; Kandus A; Kovac D
Transplant Proc; 2010 Dec; 42(10):4078-82. PubMed ID: 21168632
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
[TBL] [Abstract][Full Text] [Related]
9. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
[TBL] [Abstract][Full Text] [Related]
11. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
Dong BJ
Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
[TBL] [Abstract][Full Text] [Related]
12. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.
Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos
Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927
[TBL] [Abstract][Full Text] [Related]
13. Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.
Cohen JB; Gordon CE; Balk EM; Francis JM
Transplantation; 2012 Nov; 94(10):1041-8. PubMed ID: 23069843
[TBL] [Abstract][Full Text] [Related]
14. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
Serra AL; Wuhrmann C; Wüthrich RP
Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
[TBL] [Abstract][Full Text] [Related]
15. Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism.
Zitt E; Woess E; Mayer G; Lhotta K
Transplantation; 2011 Oct; 92(8):883-9. PubMed ID: 21876476
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
[TBL] [Abstract][Full Text] [Related]
17. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
[TBL] [Abstract][Full Text] [Related]
18. Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report.
Maass E; Mueller GA; Heller T; Koziolek MJ
Transplant Proc; 2007 Dec; 39(10):3468-70. PubMed ID: 18089410
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.
Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G
Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292
[TBL] [Abstract][Full Text] [Related]
20. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
